A detailed history of Clune & Associates, Ltd. transactions in American Centy ETF Tr Avantis stock. As of the latest transaction made, Clune & Associates, Ltd. holds 69,584 shares of AVIV stock, worth $4.7 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
69,584
Previous 63,104 10.27%
Holding current value
$4.7 Million
Previous $3.93 Billion 19.49%
% of portfolio
1.17%
Previous 1.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

BUY
$61.83 - $67.44 $400,658 - $437,011
6,480 Added 10.27%
69,584 $4.69 Billion
Q2 2025

Jul 30, 2025

BUY
$50.27 - $62.84 $19,555 - $24,444
389 Added 0.62%
63,104 $3.93 Billion
Q1 2025

Apr 28, 2025

BUY
$51.51 - $58.54 $63,769 - $72,472
1,238 Added 2.01%
62,715 $3.55 Billion
Q4 2024

Feb 11, 2025

BUY
$51.24 - $55.81 $3.15 Million - $3.43 Million
61,477 New
61,477 $3.19 Billion

Others Institutions Holding AVIV

About AMERICAN CENTY ETF TR AVANTIS


  • Ticker AVIV
More about AVIV
Track This Portfolio

Track Clune & Associates, Ltd. Portfolio

Follow Clune & Associates, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clune & Associates, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Clune & Associates, Ltd. with notifications on news.